Device type · NPT
Aortic Valve, Prosthesis, Percutaneously Delivered
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
NPT
Cardiovascular
Device class
Class III
FDA decisions since 2015
17
510(k), De Novo and PMA
Adverse event reports
12,695
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Aortic Valve, Prosthesis, Percutaneously Delivered
- Product code
- NPT
- Device class
- Class III
- Review panel
- Cardiovascular
- Specialty
- Cardiology, Interventional Cardiology
- FDA record
- Classification database entry for NPT
Latest FDA decisions
The 8 newest of 17 since 2015.
- Trilogy Transcatheter Heart Valve SystemBreakthroughPMA
P250024 · Decided Mar 17, 2026 · 260 days after receipt
Device type: Aortic valve, prosthesis, percutaneously delivered (NPT) · Cardiology
- Evolut PRO+ System, Evolut FX System, Evolut FX+ SystemPMA supplement
P130021-S174 · Decided Aug 27, 2025 · 180 days after receipt · Panel Track
Device type: Aortic valve, prosthesis, percutaneously delivered (NPT) · Cardiology
- Edwards SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve systemPMA supplement
P140031-S182 · Decided Apr 30, 2025 · 166 days after receipt · Panel Track
Device type: Aortic valve, prosthesis, percutaneously delivered (NPT) · Cardiology
P190023 · Decided Sep 17, 2021 · 739 days after receipt
Device type: Aortic valve, prosthesis, percutaneously delivered (NPT) · Cardiology
P140031-S125 · Decided May 13, 2021 · 176 days after receipt · Panel Track
Device type: Aortic valve, prosthesis, percutaneously delivered (NPT) · Cardiology
P140031-S112 · Decided Sep 9, 2020 · 177 days after receipt · Panel Track
Device type: Aortic valve, prosthesis, percutaneously delivered (NPT) · Cardiology
P130021-S058 · Decided Aug 16, 2019 · 154 days after receipt · Panel Track
Device type: Aortic valve, prosthesis, percutaneously delivered (NPT) · Cardiology
- SAPIEN 3 Ultra transcatheter heart valvePMA supplement
P140031-S085 · Decided Aug 16, 2019 · 137 days after receipt · Panel Track
Device type: Aortic valve, prosthesis, percutaneously delivered (NPT) · Cardiology
Reports received
12,695
Received Nov 1, 2025 to Nov 19, 2026. Includes 1 of another or unstated type.
Malfunction reports
2,740
22% of reports
Injury reports
8,899
70% of reports
Death reports
1,055
8.3% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 100 | 660 | 90 | 0 |
| Jan 24 | 101 | 588 | 97 | 0 |
| Feb 24 | 104 | 813 | 127 | 0 |
| Mar 24 | 123 | 799 | 150 | 0 |
| Apr 24 | 131 | 727 | 125 | 0 |
| May 24 | 143 | 584 | 60 | 0 |
| Jun 24 | 111 | 606 | 105 | 0 |
| Jul 24 | 160 | 579 | 88 | 0 |
| Aug 24 | 176 | 631 | 113 | 0 |
| Sep 24 | 139 | 515 | 48 | 0 |
| Oct 24 | 251 | 696 | 82 | 0 |
| Nov 24 | 281 | 593 | 66 | 0 |
| Dec 24 | 291 | 725 | 115 | 0 |
| Jan 25 | 355 | 588 | 93 | 0 |
| Feb 25 | 248 | 586 | 76 | 0 |
| Mar 25 | 193 | 750 | 137 | 0 |
| Apr 25 | 421 | 832 | 172 | 0 |
| May 25 | 328 | 675 | 54 | 0 |
| Jun 25 | 341 | 640 | 104 | 0 |
| Jul 25 | 399 | 766 | 107 | 0 |
| Aug 25 | 215 | 679 | 83 | 0 |
| Sep 25 | 175 | 590 | 59 | 0 |
| Oct 25 | 252 | 910 | 131 | 0 |
| Nov 25 | 215 | 656 | 64 | 0 |
| Dec 25 | 234 | 870 | 122 | 0 |
| Jan 26 | 192 | 708 | 107 | 0 |
| Feb 26 | 213 | 750 | 89 | 0 |
| Mar 26 | 267 | 842 | 133 | 0 |
| Apr 26 | 227 | 856 | 105 | 0 |
| May 26 | 212 | 782 | 74 | 0 |
| Jun 26 | 256 | 658 | 67 | 0 |
| Jul 26 | 260 | 765 | 92 | 1 |
| Aug 26 | 208 | 663 | 47 | 0 |
| Sep 26 | 211 | 630 | 62 | 0 |
| Oct 26 | 245 | 719 | 93 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Medtronic6,055
- Edwards Lifesciences4,793
- Abbott1,819
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Patient Device Interaction Problem3,104
- Adverse Event Without Identified Device or Use Problem2,231
- Perivalvular Leak1,677
- Insufficient Device Problem Information1,619
- Intravalvular regurgitation985
- Device Stenosis935
- Device Dislodged or Dislocated764
- Material Invagination689
- Calcified641
- Degraded586
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions2,943
- Insufficient Information2,075
- Heart Block1,659
- Aortic Valve Insufficiency/ Regurgitation1,137
- Dyspnea886
- Heart Failure/Congestive Heart Failure788
- Stroke/CVA770
- Valvular Insufficiency/ Regurgitation745
- Non specific EKG/ECG Changes669
- Foreign Body In Patient550
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- JenaValve Trilogy Delivery Catheter, Size 23MM REF: TRILOGY-DC-SOpen, Classified
Z-0134-2027 · Started Jul 31, 2026 · Posted by FDA Oct 9, 2026
Reason given: Delivery Catheter may have sleeve liner separation that results in difficulty or inability to deploy heart valve device.
Cause as FDA categorized it: Nonconforming Material/Component
- JenaValve Trilogy Delivery Catheter, Size 25MM REF: TRILOGY-DC-MOpen, Classified
Z-0135-2027 · Started Jul 31, 2026 · Posted by FDA Oct 9, 2026
Reason given: Delivery Catheter may have sleeve liner separation that results in difficulty or inability to deploy heart valve device.
Cause as FDA categorized it: Nonconforming Material/Component
- JenaValve Trilogy Delivery Catheter, Size 27MM REF: TRILOGY-DC-LOpen, Classified
Z-0136-2027 · Started Jul 31, 2026 · Posted by FDA Oct 9, 2026
Reason given: Delivery Catheter may have sleeve liner separation that results in difficulty or inability to deploy heart valve device.
Cause as FDA categorized it: Nonconforming Material/Component
- Abbott Navitor Titan, Vision Technology, Transcatheter Aortic Heart Valve, 35 mm, NVRO-35, SterileOpen, Classified
Z-0491-2025 · Started Oct 17, 2024 · Posted by FDA Nov 20, 2024
Reason given: A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the impacted valve and/or cause potential valve failure.
Cause as FDA categorized it: Under Investigation by firm
Z-0492-2025 · Started Oct 17, 2024 · Posted by FDA Nov 20, 2024
Reason given: A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the impacted valve and/or cause potential valve failure.
Cause as FDA categorized it: Under Investigation by firm
- Abbot Navitor, Vision Technology, Transcatheter Aortic Heart Valve, 29 mm, NVRO-29, SterileOpen, Classified
Z-0493-2025 · Started Oct 17, 2024 · Posted by FDA Nov 20, 2024
Reason given: A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the impacted valve and/or cause potential valve failure.
Cause as FDA categorized it: Under Investigation by firm
- Abbott Navitor, Vision Technology, Transcatheter Aortic Heart Valve, 27 mm, NVRO-27, SterileOpen, Classified
Z-0494-2025 · Started Oct 17, 2024 · Posted by FDA Nov 20, 2024
Reason given: A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the impacted valve and/or cause potential valve failure.
Cause as FDA categorized it: Under Investigation by firm
Z-0495-2025 · Started Oct 17, 2024 · Posted by FDA Nov 20, 2024
Reason given: A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the impacted valve and/or cause potential valve failure.
Cause as FDA categorized it: Under Investigation by firm
Showing the 8 newest of 36 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.